Back
Speaker illustration

Doctor Samuel Dagogo-Jack

Memphis (United States of America)

Presentations

VERTIS CV Safety Results and Conclusions.

Event: ESC Congress 2020

Topic: Diabetes and the Heart

Session: Expanding Understanding For Patients With Diabetes and Cardiovascular Disease – Results From The VERTIS CV Trial

Access
Like
Thumbnail

VERTIS CV – New Information For the Treatment for Patients With Type 2 Diabetes and Cardiovascular Disease.

Event: ESC Congress 2020

Topic: Diabetes and the Heart

Session: Expanding Understanding For Patients With Diabetes and Cardiovascular Disease – Results From The VERTIS CV Trial

Access
Like
Thumbnail

Envisioning the future of SGLT2 inhibitors in the treatment of patients with diabetes and cardiovascular disease: a roundtable discussion.

Event: ESC Congress 2018

Topic: Cardiovascular Disease in Special Populations

Session: Five things cardiologists should know about diabetes

Access
Like
Thumbnail

Questions & Answers.

Event: ESC Congress 2018

Topic: Cardiovascular Disease in Special Populations

Session: Five things cardiologists should know about diabetes

Access
Like
Thumbnail

Ertugliflozin – A newly emerging SGLT2 inhibitor for patients with type 2 diabetes.

Event: ESC Congress 2018

Topic: Cardiovascular Disease in Special Populations

Session: Five things cardiologists should know about diabetes

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources